Author

Schito AM

Scientific Director - Cited by 9,913 - antimicrobial drug resistance - next generation sequencing - diagnostics

Biography

Schito AM  DISC, Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy Also sometimes referred to as intensivists, critical care specialists are physicians with specialized training in the diagnosis and management of life-threatening conditions, such as those that affect vital organs like the heart and lungs, those that make breathing difficult or impossible, and those that affect entire organ systems, like the renal system. Critical care specialists are typically found in a hospital's intensive care unit where they monitor patients with life-threatening conditions and make determinations as to the best course of treatment.
Title
Cited by
Year
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
AI Zumla, SH Gillespie, M Hoelscher, PPJ Philips, ST Cole, I Abubakar, ...The Lancet infectious diseases 14 (4), 327-340, 2014201
402
2014
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...European Respiratory Journal 50 (6), 2017201
327
2017
Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
RS Wallis, M Maeurer, P Mwaba, J Chakaya, R Rustomjee, GB Migliori, ...The Lancet infectious diseases 16 (4), e34-e46, 2016201
287
2016
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes ProjectNew England Journal of Medicine 379 (15), 1403-1415, 2018201
278
2018
Clinical case definitions for classification of intrathoracic tuberculosis in children: an update
SM Graham, LE Cuevas, P Jean-Philippe, R Browning, M Casenghi, ...Clinical Infectious Diseases 61 (suppl_3), S179-S187, 2015201
262
2015
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
CJ Meehan, GA Goig, TA Kohl, L Verboven, A Dippenaar, M Ezewudo, ...NATURE reviews microbiology 17 (9), 533-545, 2019201
255
2019
Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
SHE Kaufmann, C Lange, M Rao, KN Balaji, M Lotze, M Schito, AI Zumla, ...The lancet Respiratory medicine 2 (4), 301-320, 2014201
243
2014
Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects
M Pai, M SchitoThe Journal of infectious diseases 211 (suppl_2), S21-S28, 2015201
210
2015
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
M Zignol, AS Dean, N Alikhanova, S Andres, AM Cabibbe, DM Cirillo, ...The Lancet infectious diseases 16 (10), 1185-1192, 2016201
191
2016
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
M Zignol, AM Cabibbe, AS Dean, P Glaziou, N Alikhanova, C Ama, ...The Lancet Infectious Diseases 18 (6), 675-683, 2018201
140
2018
Defining the needs for next generation assays for tuberculosis
CM Denkinger, SV Kik, DM Cirillo, M Casenghi, T Shinnick, K Weyer, ...The Journal of infectious diseases 211 (suppl_2), S29-S38, 2015201
138
2015
Towards host-directed therapies for tuberculosis
A Zumla, J Chakaya, M Hoelscher, F Ntoumi, R Rustomjee, C Vilaplana, ...Nature reviews Drug discovery 14 (8), 511-512, 2015201
118
2015
HIV-1 drug resistance mutations: potential applications for point-of-care genotypic resistance testing
SY Rhee, MR Jordan, E Raizes, A Chua, N Parkin, R Kantor, GU Van Zyl, ...PloS one 10 (12), e0145772, 2015201
93
2015
Collaborative effort for a centralized worldwide tuberculosis relational sequencing data platform
AM Starks, E Avilés, DM Cirillo, CM Denkinger, DL Dolinger, C Emerson, ...Clinical Infectious Diseases 61 (suppl_3), S141-S146, 2015201
88
2015
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
M Ezewudo, A Borens, Á Chiner-Oms, P Miotto, L Chindelevitch, ...Scientific reports 8 (1), 15382, 2018201
73
2018
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ...The Lancet Microbe 3 (4), e265-e273, 2022202
71
2022
Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction
ML Chen, A Doddi, J Royer, L Freschi, M Schito, M Ezewudo, IS Kohane, ...EBioMedicine 43, 356-369, 2019201
58
2019
Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action
R McNerney, TG Clark, S Campino, C Rodrigues, D Dolinger, L Smith, ...International Journal of Infectious Diseases , 130-135, 2017201
56
2017
Bedaquiline microheteroresistance after cessation of tuberculosis treatment
M De Vos, SD Ley, KB Wiggins, B Derendinger, A Dippenaar, ...New England Journal of Medicine 380 (22), 2178-2180, 2019201
52
2019
Development of a contemporary globally diverse HIV viral panel by the EQAPOL program
AM Sanchez, CT DeMarco, B Hora, S Keinonen, Y Chen, C Brinkley, ...Journal of immunological methods 409, 117-130, 2014201
49
2014

Referred From: https://scholar.google.de/citations?user=7KNlILQAAAAJ&hl=en

Cited by
Citations 9913
h-index 46
i10-index 80
Recommended Journals
Open Access Journals